Recently, a study in transgenic AD mice demonstrated that the use of C. butyricum attenuated the Aβ pathological load in the brains of APP/PS1 mice, accompanied by an increase in gut butyric acid levels. The gene discussed is APP; the disease is Alzheimer disease.